| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 191.109 | 83 |
| GSM780708 | Untreated after 4 days (C2_1) | 96.0049 | 75 |
| GSM780709 | Untreated after 4 days (C3_1) | 95.1413 | 74 |
| GSM780719 | Untreated after 4 days (C1_2) | 153.202 | 81 |
| GSM780720 | Untreated after 4 days (C2_2) | 104.731 | 76 |
| GSM780721 | Untreated after 4 days (C3_2) | 108.246 | 76 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 108.789 | 76 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 132.212 | 79 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 212.032 | 84 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 104.058 | 76 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 106.22 | 76 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 209.124 | 84 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 101.975 | 75 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 109.05 | 76 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 110.536 | 77 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 93.3382 | 74 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 90.7032 | 74 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 124.69 | 78 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 90.3984 | 74 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 79.997 | 72 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 110.741 | 77 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 94.3949 | 74 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 95.862 | 75 |